Skip to main content

The Leukodystrophy and Myelin Disorders team is internationally renowned for leukodystrophies and genetic leukoencephalopathies research. The program applies a “bench-to-bedside” approach and makes cutting-edge treatments available to patients. 

For more information about our program, current studies or research programs, please email Jamie Fraser, M.D., (PI) or our team.


Our Research Projects

The Global Leukodystrophy InitiAtive (GLIA)

The Myelin Disorders Bioregistry Project (MDBP)

Unsolved Leukodystrophies